Europe — EMA

Oksaliplatin Sandoz (Oxaliplatin)

Oxaliplatin, the active ingredient in Oksaliplatin Sandoz, is a platinum‑based chemotherapy agent presented as a sterile injectable solution for intravenous use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oksaliplatin Sandoz, is a platinum‑based chemotherapy agent presented as a sterile injectable solution for intravenous use. It is employed in the treatment of colorectal cancer, typically in combination with other chemotherapeutic drugs, and is used in adult patients.

GNH USA supplies Oksaliplatin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Oxaliplatin used for?

Oksaliplatin Sandoz is a platinum‑based chemotherapeutic that acts on rapidly growing cancer cells, particularly within the gastrointestinal tract.

- Colorectal cancer: improves response rates when combined with 5‑fluorouracil and leucovorin. - Gastric cancer: used as the ‑ ... - Advanced ... ... g ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →